These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
545 related items for PubMed ID: 15549428
1. Pathogenesis of carcinoma of the papilla of Vater. Fischer HP, Zhou H. J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428 [Abstract] [Full Text] [Related]
2. [Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings]. Fischer HP, Zhou H. Pathologe; 2003 May; 24(3):196-203. PubMed ID: 12739053 [Abstract] [Full Text] [Related]
3. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Zhou H, Schaefer N, Wolff M, Fischer HP. Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956 [Abstract] [Full Text] [Related]
4. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater. Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H, Saito T. Cancer; 1999 Aug 15; 86(4):596-607. PubMed ID: 10440687 [Abstract] [Full Text] [Related]
5. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis. Roh YH, Kim YH, Lee HW, Kim SJ, Roh MS, Jeong JS, Jung GJ. Hepatogastroenterology; 2007 Sep 15; 54(78):1641-4. PubMed ID: 18019683 [Abstract] [Full Text] [Related]
6. Does ampullary carcinoma arise from distended glands in the papilla of Vater? Sonoue H, Suda K, Nobukawa B, Abe H, Arakawa A, Hirai S, Matsumoto T. J Hepatobiliary Pancreat Surg; 2008 Sep 15; 15(2):161-8. PubMed ID: 18392709 [Abstract] [Full Text] [Related]
7. Neoplastic diseases of the papilla of Vater. Kimura W, Futakawa N, Zhao B. J Hepatobiliary Pancreat Surg; 2004 Sep 15; 11(4):223-31. PubMed ID: 15368105 [Abstract] [Full Text] [Related]
8. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes. Sanada Y, Yoshida K, Konishi K, Oeda M, Ohara M, Tsutani Y. Oncol Rep; 2006 May 15; 15(5):1157-61. PubMed ID: 16596179 [Abstract] [Full Text] [Related]
9. Total papillectomy for borderline malignant tumor of papilla of Vater. Moriya T, Kimura W, Hirai I, Sakurai F, Isobe H, Ozawa K, Fuse A. Hepatogastroenterology; 2004 May 15; 51(57):859-61. PubMed ID: 15143934 [Abstract] [Full Text] [Related]
10. Tumors of the ampulla of vater: histopathologic classification and predictors of survival. Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW. J Am Coll Surg; 2008 Aug 15; 207(2):210-8. PubMed ID: 18656049 [Abstract] [Full Text] [Related]
11. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Goldstein NS, Bassi D. Am J Clin Pathol; 2001 May 15; 115(5):695-702. PubMed ID: 11345833 [Abstract] [Full Text] [Related]
12. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA. Sato T, Konishi K, Kimura H, Maeda K, Yabushita K, Tsuji M, Miwa A. Hepatogastroenterology; 1999 May 15; 46(27):1959-62. PubMed ID: 10430377 [Abstract] [Full Text] [Related]
13. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival. Morini S, Perrone G, Borzomati D, Vincenzi B, Rabitti C, Righi D, Castri F, Manazza AD, Santini D, Tonini G, Coppola R, Onetti Muda A. Pancreas; 2013 Jan 15; 42(1):60-6. PubMed ID: 22889982 [Abstract] [Full Text] [Related]
14. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance]. Liu FF, Shen DH, Wang HL, Ma YT, Yuan F, Liu J, Chen L, Song QJ, Zhang YY. Zhonghua Bing Li Xue Za Zhi; 2019 Feb 08; 48(2):92-97. PubMed ID: 30695858 [Abstract] [Full Text] [Related]
15. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Takashima M, Ueki T, Nagai E, Yao T, Yamaguchi K, Tanaka M, Tsuneyoshi M. Mod Pathol; 2000 Dec 08; 13(12):1300-7. PubMed ID: 11144926 [Abstract] [Full Text] [Related]
16. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases. Handra-Luca A, Terris B, Couvelard A, Bonte H, Flejou JF. Mod Pathol; 2003 Jun 08; 16(6):530-6. PubMed ID: 12808057 [Abstract] [Full Text] [Related]
17. A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer. Hirono S, Tani M, Terasawa H, Kawai M, Ina S, Uchiyama K, Nakamura Y, Kakudo K, Yamaue H. Hepatogastroenterology; 2008 Jun 08; 55(84):861-4. PubMed ID: 18705284 [Abstract] [Full Text] [Related]
18. Frequency of colorectal polyps in patients with sporadic adenomas or adenocarcinomas of the papilla of vater--an age-matched, controlled study. Schneider AR, Seifert H, Trojan J, Stein J, Hoepffner NM. Z Gastroenterol; 2005 Oct 08; 43(10):1123-7. PubMed ID: 16220451 [Abstract] [Full Text] [Related]
19. Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study. Seifert E, Schulte F, Stolte M. Am J Gastroenterol; 1992 Jan 08; 87(1):37-42. PubMed ID: 1728122 [Abstract] [Full Text] [Related]
20. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM. Am J Surg Pathol; 2005 Mar 08; 29(3):359-67. PubMed ID: 15725805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]